Drug Shortage Report for ASMANEX TWISTHALER
Report ID | 179906 |
Drug Identification Number | 02438690 |
Brand name | ASMANEX TWISTHALER |
Common or Proper name | mometasone furoate dry powder inhaler |
Company Name | ORGANON CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | MOMETASONE FUROATE |
Strength(s) | 100MCG |
Dosage form(s) | POWDER |
Route of administration | INHALATION INHALATION |
Packaging size | 30 |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-01-05 |
Estimated end date | 2023-03-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2023-01-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2023-01-06 | English | Compare |
v2 | 2023-01-05 | French | Compare |
v1 | 2023-01-05 | English | Compare |
Showing 1 to 3 of 3